Pharma Business Daily
Claim your FREE trial subscription!


Medical Devices:

Medical Device Coatings

BCC Research
Market Study  April 2006

Paper - USD 4250.00  
Single-user PDF - USD 4850.00  


Table of Contents

In this report, BCC Research examines medical device coatings, the most rapidly expanding sector of the $213-billion global medical device market. These coatings increase the functionality, longevity and cost-effectiveness of medical devices. They have been so effective that over the last decade the medical community rapidly accepted drug eluting coatings and streamlined the regulatory process with the creation of the FDA Office of Combination Products. As a result, pure-play medical device coating enterprises have grown swiftly. This comprehensive analysis examines the market for these heavily regulated products and forecasts the direction of the medical device coatings through 2010.

This report:

- Analyzes the markets for medical device coatings and surface treatment technologies worldwide, by medical specialty and material, with forecasts through 2010.
- Examines the seven basic types of materials currently used to create coatings for more than 92,000 unique medical devices.
- Explains how the successful commercialization of engineered alloys, ceramics and polymers has transformed coatings from passive to active components in medical devices.
- Discusses changing medical needs that are accelerating the future demand for coated medical products.
- Reviews more than 200 patents and profiles key coating and medical device suppliers.

Report Highlights:

- The value of the worldwide sales for all categories of coatings and surface treatment processes used in manufacturing medical devices reached $2.96 billion in 2005.
- Fueled by an explosive growth in high-value combination products, such as arterial stents and antimicrobal-coated catheters, the global medical device coatings business will experience an average annual growth rate (AAGR) of 12.4%, reaching worldwide sales of $5.31 billion by 2010.
- The swift acceptance of drug-eluting stents as a "gold standard" treatment by surgeons around the globe suggests that the demand for other coated versions of existing medical devices will be equally swift. Our analysis further suggests that there will be a corresponding swift acceptance of new coated devices as they are introduced.





For full details, please email jenniferc@cmsinfo.com

Order Form




CMS, P&A House, Alma Road, Chesham, Bucks. HP5 3HB, UK
Tel:     +44 (0)1494 771734
Fax:   +44 (0)1494 778994
e-mail: Jennifer Cowlard
copyright © 2008 all rights reserved

For more information about us, visit CMSinfo.

footer bar